Browsing by Author "Palomera, Luis"

Sort by: Order: Results:

  • Sánchez-Martínez, Diego; Lanuza, Pilar M.; Gómez, Natalia; Muntasell i Castellví, Aura, 1972-; Cisneros, Elisa; Moraru, Manuela; Azaceta, Gemma; Anel, Alberto; Martínez-Lostao, Luis; Villalba, Martin; Palomera, Luis; Vilches, Carlos; García Marco, José A.; Pardo, Julián (Frontiers, 2016)
    Mutational status of TP53 together with expression of wild-type (wt) IGHV represents the most widely accepted biomarkers, establishing a very poor prognosis in B-cell chronic lymphocytic leukemia (B-CLL) patients. Adoptive ...
  • Steegmann, Juan Luis; Colomer Pujol, Dolors; Gómez-Casares, Maria-Teresa; García-Gutiérrez, Valentín; Ortí, Guillermo; Ramírez-Payer, Angel; Olavarria, Eduardo; Vall-llovera, Ferrán; Giraldo, Pilar; Conde, Eulogio; Vallansot, Rolando; López-Lorenzo, Jose Luis; Palomera, Luis; Alvarez-Larrán, Alberto; Conesa, Venancio; Bautista, Guiomar; Casas, Laura; Giles, Frank; Hochhaus, Andreas; Casado-Montero, Luis Felipe (SpringerOpen, 2017)
    PURPOSE: This study was aimed to analyze the association of very early molecular response to nilotinib with the achievement of deep molecular response (MR4) at 18 months. We hypothesized that the BCR-ABL1 levels during the ...
  • García-Sanz, Ramón; Albert, Oriol; Moreno, María J.; Rubia, Javier de la; Payer, Angel R.; Hernández, Miguel T.; Palomera, Luis; Teruel, Ana I.; Blanchard, María J.; Gironella, Mercedes; Ribas, Paz; Bargay, Joan; Abella Monreal, Eugenia; Granell, Miquel; Ocio, Enrique M.; Ribera, Josep Maria; San Miguel, Jesús F.; Mateos, María V.; Spanish Myeloma Group (GEM/PETHEMA). (Ferrata Storti Foundation, 2015)
    This study analyzed the anti-myeloma effect of zoledronic acid monotherapy by investigating patients at the time of asymptomatic biochemical relapse. One hundred patients were randomized to receive either zoledronic acid ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking